Compare Cisco Systems Inc (CSCO) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cisco Systems Inc vs Quest Diagnostics Inc — how do they compare? Cisco Systems Inc trades at $114.76 (market cap $488.26B), while Quest Diagnostics Inc trades at $237.17 (market cap $26.24B). The key difference: Cisco Systems Inc is far larger — about 18.6× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| CSCO | DGX | |
|---|---|---|
Market Cap | $488.26B | $26.24B |
Volume | 22,887,319 | — |
Sector | Technology | Health |
52-Week High | $130.00 | $238.50 |
52-Week Low | $66.20 | $173.49 |
Enterprise Value | $501.88B | $32.00B |
Dividend Yield | 1.36% | 1.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $120.43, down 1.75% on the day, but maintains strong technical momentum with a bullish moving average signal. The company has delivered four consecutive quarterly earnings beats, with Q2 2026 EPS of $1.22 exceeding expectations. Recent AI cybersecurity partnerships and product launches have driven positive sentiment, though valuation metrics remain elevated with a P/E of 40.14.
The outlook remains positive with analyst consensus pointing to 11% upside to the $133.60 price target. Key opportunities include Cisco's strategic positioning in AI infrastructure and cybersecurity, while risks include competitive pressures and the stock's premium valuation. Institutional ownership remains strong with 52% of analysts maintaining buy ratings.
Quest Diagnostics (DGX) trades at $237.99, up 0.15% on the day, near its 52-week high. The stock shows strong momentum with consecutive earnings beats in 2026, including Q2 EPS of $3.12 versus $2.82 expected. Revenue growth accelerated to $11.04 billion in 2025, with net income margin at 9.19%. Technical indicators signal a bullish trend, while analyst consensus is a $249.50 price target. Recent news highlights AI integration and raised 2026 outlook amid robust testing demand.
The outlook for DGX is positive, driven by earnings momentum, strategic partnerships, and healthcare demand. Investment opportunity lies in sustained growth and dividend yield, but risks include margin pressure from lower-margin deals and high debt levels. Valuation at a P/E of 25.21 requires continued execution to justify upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cisco Systems Inc
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
